AARTIIND

Recent updates and lesser known facts about the stock

📰 Recent Updates Upgrade by UBS UBS upgraded Aarti Industries from “Sell” to “Buy,” citing signs of operational improvement and recovery in the MMA (Methyl Methacrylate) business. Along with that, the target price was raised to ₹625, implying significant upside from then-current levels. Sales Drop YoY The company’s consolidated net sales for certain quarters have declined year-on-year. For example, in June 2025, net sales dropped ~9.7% YoY in its consolidated numbers. Target Prices by Brokers Vary Different brokerages are giving different outlooks. Some see upside (targets in the ₹520-₹550 range), others are more cautious (targets around ₹420). Focus on Sustainable Growth & Capex The long-term view is that Aarti is investing its capital in expanding capacities (e.g. in nitrotoluene, speciality chemical segments) and upgrading assets, which could improve margins in future. Also, efforts to reduce dependence on China and strengthen backward integration are part of its strategy. Debt Stress Signs Debt has been rising; net debt is large compared to cash reserves. There’s concern over how much of its earnings are eaten up by interest payments. Some quarters free cash flow has been weak or negative. 🔍 Hidden / Lesser-Known Facts & Risks Here are some things that aren’t always obvious but matter: Interest Cover is Weak The company’s ability to cover interest expenses has declined. That means periods of low revenue or margin compression could hit it hard, since fixed interest outflows remain. Free Cash Flow Issues Even if profits are reported, converting that into free cash flow (actual cash after operations and capital expenditures) has been challenging. This limits flexibility (for debt repayment, dividends, reinvestment).